Myopia clinical trials

Explore recruiting myopia clinical trials.

Recruiting myopia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Myopia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Investigator led, double-masked, multicentre, randomized clinical trial for the comparison of atropine 0.5% versus atropine 0.05% eye drops for the prevention of myopia progression in Dutch children

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A phase III, randomized, double-masked, placebocontrolled, parallel-group, multicenter study of the safety and efficacy of OT-101 (Atropine Sulfate 0.01%) in treating the progression of myopia in pediatric subjects

Ireland, Slovakia, Hungary, Poland, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A phase III, randomized, double blind, multiple doses, placebo-controlled parallel-group, adaptive study to evaluate the efficacy of atropine to treat the progression of myopia in children and adolescents from 3 to less than 18 years of age (MODERATO Study)

Poland, Italy, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Multicenter, Randomized, Double-Masked, Vehicle-Controlled Study to Assess the Safety and Efficacy of SYD-101 Ophthalmic Solution for the Treatment of Myopia in Children

Slovakia, Austria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Postmarketing Parallel Randomized Clinical Trial to Determine the Efficacy and Safety of Atropine and DIMS Lenses in the Control of Myopia in a Pediatric Population

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Brimonidine eye drops in the prevention of myopia progression

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Myopia trials by city

Myopia in Toronto Myopia in Vancouver Myopia in Montreal Myopia in Calgary Myopia in Edmonton Myopia in Ottawa Myopia in Winnipeg Myopia in Quebec City Myopia in Hamilton Myopia in Kitchener Myopia in London Myopia in Halifax Myopia in New York Myopia in Los Angeles Myopia in Chicago Myopia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease